|
|||||
|
|
Discontinued drugs in 2010: cardiovascular drugs |
|
| Abstract: | This perspective is a paper discussing drugs dropped from clinical development in the previous years. Specifically, this paper focuses on 16 cardiovascular drugs discontinued in 2010 after reaching Phase I – III clinical trials. Information for this perspective is mainly derived from a search of Pharmaprojects. |
| Keywords: | acadesine ataciguat atherosclerosis therapy – Lilly-2 AZD-0837 AZD-1305 AZD-6482 caldaret candesartan + pioglitazone darusentan eribaxaban fenofibrate + pravastatin fenofibrate + rosuvastatin-2 KRP-105 LCI-699 piboserod SAR-407899 |